A review from five studies has found no added benefit of using Daiichi Sankyo’s Radicava (edaravone) and Sanofi’s Rilutek ...
As the state begins revising education standards for including tribal perspectives, culture and history, some schools ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results